Suraksha Diagnostic Financial Results
Suraksha Diagnostic Limited approved its FY2025-26 audited financial results and recommended a ₹0.50 dividend. The board also appointed new internal and cost auditors for FY2026-27.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
33 announcements with these filters
Suraksha Diagnostic Limited approved its FY2025-26 audited financial results and recommended a ₹0.50 dividend. The board also appointed new internal and cost auditors for FY2026-27.
Suraksha Diagnostic will hold a board meeting on May 21, 2026, to consider audited yearly results and final dividend. Trading window remains closed until May 23.
Suraksha Diagnostic Limited submitted its quarterly certificate under SEBI Regulation 74(5) for the period ended March 31, 2026. The registrar, KFin Technologies, confirmed that no shares were received for dematerialization or rematerialization during the quarter.